Byetta contains immediate-release exenatide. Its twice-daily, meal-related use and multidose pen distinguish it from once-weekly extended-release exenatide.
The approved uses and formulations described here follow US prescribing information. They may differ in other countries.
| Medicine detail | Details |
|---|---|
| Active ingredient(s) | exenatide |
| Medicine class | GLP-1 receptor agonist |
| Forms and strengths | Immediate-release multidose pens delivering 5 or 10 micrograms per dose |
Where Byetta fits
The US label covers adults with type 2 diabetes alongside diet and exercise. Exenatide activates the GLP-1 receptor and affects glucose-dependent insulin release and other processes involved in glucose control. Byetta is not a substitute for insulin and is not treatment for diabetic ketoacidosis.
Dose per injection and pen contents
Byetta pens deliver either 5 or 10 micrograms per injection, with 60 doses in each pen. The two presentations contain different total volumes. Check the dose delivered with each injection when identifying the prescribed pen; the total amount inside it is not one injection dose.
When Byetta is taken
Byetta is injected before two main meals separated by at least about six hours, rather than after a meal. Follow the timing on the prescription and in the supplied instructions. The once-weekly schedule for Bydureon BCise does not apply to Byetta.
Safety issues to recognize
Pancreatitis, kidney injury, severe gastrointestinal problems and immune-mediated thrombocytopenia are important labeled concerns. A history of exenatide-induced immune thrombocytopenia is a contraindication. Nausea is common, and hypoglycemia risk increases with medicines such as sulfonylureas or insulin.
Brand and generic exenatide
FDA reported approval of a generic equivalent to Byetta in 2024. This does not guarantee stock at a particular pharmacy. Ask the pharmacist whether the proposed product matches the prescribed immediate-release formulation and device. Weekly extended-release exenatide is a different product.
Questions and answers
Does Byetta have the same schedule as Bydureon?
No. Byetta is an immediate-release product used around meals; BCise is a weekly extended-release product.
How many doses are in a labeled Byetta pen?
The pen provides 60 doses at its specified dose strength.
Does generic approval mean all exenatide products are interchangeable?
No. Formulation and reference product matter, and substitution must follow the prescription and applicable rules.
Related reading
Sources
Sources checked 1 October 2026. This information does not replace advice from your healthcare professional. For complete warnings and instructions, read the product information and consult the prescribing team.
Reviewed by: Mattias Hagman, PhD
About the reviewer:
Dr Mattias Hagman (PhD, University of Sydney) has an academic background and experience working with healthcare-related content and regulated industries. He has lecturing experience at international universities, including Stockholm University and the University of Malta.
Last reviewed: October 2026